Likewise, we demonstrate for the first time that treatment of MG63 osteosarcoma cells with recombinant biglycan increases β-catenin expression and mediates its cellular deposition and enhancingβ-catenins' cell membrane and cytoplasmic localizations. Here, BGN is linked to osteosarcoma.